TP53 and cancer: Other mechanisms (such as MDM-2 amplification, PPMID mutation, inactivation of cell death pathways) can result in the indirect loss of p53 activity and tumor suppression, resulting in at least to 80% of the human cancers having dysfunctional p53 pathways [13].